ATE446088T1 - Epigallocatechin-gallate zur hemmung von angiogenese - Google Patents

Epigallocatechin-gallate zur hemmung von angiogenese

Info

Publication number
ATE446088T1
ATE446088T1 AT01900994T AT01900994T ATE446088T1 AT E446088 T1 ATE446088 T1 AT E446088T1 AT 01900994 T AT01900994 T AT 01900994T AT 01900994 T AT01900994 T AT 01900994T AT E446088 T1 ATE446088 T1 AT E446088T1
Authority
AT
Austria
Prior art keywords
gallate
epigallocatechin
inhibiting angiogenesis
treatment
angiogenesis
Prior art date
Application number
AT01900994T
Other languages
English (en)
Inventor
Jon Anderson
Mary Matsui
Original Assignee
Color Access Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Color Access Inc filed Critical Color Access Inc
Application granted granted Critical
Publication of ATE446088T1 publication Critical patent/ATE446088T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01900994T 2000-01-14 2001-01-11 Epigallocatechin-gallate zur hemmung von angiogenese ATE446088T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/483,952 US6248341B1 (en) 2000-01-14 2000-01-14 Method of treating topical angiogenesis-related disorders
PCT/US2001/001019 WO2001051048A1 (en) 2000-01-14 2001-01-11 Use of epigallocatechin-gallate for inhibiting angiogenesis

Publications (1)

Publication Number Publication Date
ATE446088T1 true ATE446088T1 (de) 2009-11-15

Family

ID=23922155

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01900994T ATE446088T1 (de) 2000-01-14 2001-01-11 Epigallocatechin-gallate zur hemmung von angiogenese

Country Status (10)

Country Link
US (1) US6248341B1 (de)
EP (1) EP1162968B1 (de)
JP (1) JP2003519654A (de)
AT (1) ATE446088T1 (de)
AU (1) AU781949B2 (de)
CA (1) CA2366621A1 (de)
DE (1) DE60140234D1 (de)
ES (1) ES2332704T3 (de)
HK (1) HK1043052B (de)
WO (1) WO2001051048A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696484B2 (en) 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity
EP1027045A4 (de) * 1997-10-31 2004-12-08 Arch Dev Corp Methoden und zusammenstellungen zur regelierung des s-alpha-reduktaseaktivität
US7338971B2 (en) * 2001-08-30 2008-03-04 El-Naggar Mawaheb M Treatment of inflammatory, cancer, and thrombosis disorders
MXPA04004532A (es) 2001-11-19 2004-08-11 Medigene Ag Medicamento para el tratamiento de enfermedades tumorales y virales de la piel.
US7678549B2 (en) * 2001-12-28 2010-03-16 Research Development Foundation Polyphenol inhibition of nucleoside diphosphate kinase-B activity and cancer metastasis
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US7108868B2 (en) * 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US7260253B2 (en) * 2002-04-19 2007-08-21 Visiongate, Inc. Method for correction of relative object-detector motion between successive views
BRPI0309689B1 (pt) * 2002-04-30 2021-06-29 Unigen, Inc Composições compreendendo uma mistura de flavonóides de anel-b-livre e flavanos e usos das mesmas
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
FR2842102B1 (fr) * 2002-07-10 2005-10-28 Cep Utilisation d'un extrait de the pour controler la liberation d'il8, cytokine pro-inflammatoire et son incorporation dans des preparations cosmetiques et/ou dermatologiques
PT102931B (pt) * 2003-03-28 2005-08-31 Univ Do Porto Utilizacao de bloqueadores da inibicao a longo termo das actividades da atpase na+k+e/ou do trocador na+/h+, na preparacao de um medicamento destinado a terapiaintestinal
US20040220119A1 (en) * 2003-04-04 2004-11-04 Unigen Pharmaceuticals, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
EP1660109A4 (de) * 2003-09-02 2009-04-08 Unigen Pharmaceuticals Inc Formulierung eines gemisches aus freien-b-ring flavonoiden und flavanen zur verwendung bei der prävention und behandlung von kognitiver verschlechterung und altersbedingten gedächtnisstörungen
US7910138B2 (en) * 2003-10-09 2011-03-22 Medigene Ag Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin
AU2005265249A1 (en) * 2004-06-22 2006-01-26 E-L Management Corp. Dissolvable film composition
KR100545304B1 (ko) * 2004-09-01 2006-05-08 주식회사 유니젠 아선약을 포함하는 운카리아 속 식물, 또는 이의 황금및/또는 녹차의 배합물을 포함하는 사이클로옥시게나제및/또는 5-리폭시게나제 억제용 조성물
US7494809B2 (en) * 2004-11-09 2009-02-24 Visiongate, Inc. Automated cell sample enrichment preparation method
WO2006135785A2 (en) * 2005-06-10 2006-12-21 Medical College Of Georgia Research Institute Compositions and methods for treating immune disorders
US9446017B2 (en) 2005-08-11 2016-09-20 Augusta University Research Institute, Inc. Compositions and methods for treating herpes simplex virus
JP5192380B2 (ja) 2005-09-08 2013-05-08 株式會社アモーレパシフィック 皮膚老化防止用皮膚外用剤組成物
CN102985068B (zh) 2010-05-18 2014-10-22 荷兰联合利华有限公司 个人护理组合物
JP2021532079A (ja) * 2018-07-12 2021-11-25 オキュソフト インコーポレイテッドOCuSOFT, Inc. 目の抗アレルギ用組成物および眼瞼洗浄ワイプ

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52136909A (en) 1976-05-06 1977-11-16 Ichirou Yamashita Preparation of cell activator
JP2519024B2 (ja) * 1982-06-07 1996-07-31 花王株式会社 毛髪化粧料
JPS6281303A (ja) * 1985-10-01 1987-04-14 Mitsubishi Chem Ind Ltd 皮膚外用基剤
DE4027350A1 (de) 1990-08-30 1992-03-05 Karin Omlor Mittel auf pflanzlicher basis zur regeneration der haut bei frischen brandverletzungen, zur reinigung unreiner haut zur bekaempfung von krampfadern, bei aeusserlicher anwendung
DE4138192A1 (de) 1990-08-30 1993-05-27 Karin Omlor Mittel auf pflanzlicher basis, zur erneuerung der haut bei frischen brandverletzungen, zur reinigung unreiner haut, zur bekaempfung von krampfadern, zum abklingen von schwellungen bei verletzungen, zum abklingen von schwellungen und juckreiz bei insektenstichen, bei aeusserlicher anwendung
JPH05109110A (ja) 1991-10-16 1993-04-30 Sony Corp 光学ピツクアツプ装置
US5605929A (en) * 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
JP2691662B2 (ja) 1992-07-08 1997-12-17 花王株式会社 化粧料
US5391568A (en) * 1992-07-10 1995-02-21 American Health Foundation Inhibition of lung tumorigenesis by administration of a polyphenol
JPH06172122A (ja) * 1992-08-31 1994-06-21 Uenoya Honpo:Kk 化粧品の製造方法
FR2699818B1 (fr) 1992-12-24 1995-02-03 Oreal Composition cosmétique ou pharmaceutique contenant en association un polyphénol et un extrait de gingko.
JP2764510B2 (ja) 1992-12-28 1998-06-11 花王株式会社 美白化粧料
US5306486A (en) * 1993-03-01 1994-04-26 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic sunscreen composition containing green tea and a sunscreen
JPH0725742A (ja) 1993-07-15 1995-01-27 Kao Corp 美白化粧料
EP0716589A4 (de) * 1993-07-23 1997-06-11 Morris Herstein Kosmetische, die hauterneuerung stimulierende zusammensetzung mit langzeit-irritationskontrolle
US5670154A (en) 1994-01-10 1997-09-23 Mitsui Norin Co., Ltd. Reducing tyrosinase activity
GB2293548A (en) 1994-09-29 1996-04-03 Joan Louise Hibberd Treatment of herpes infections
RU2157695C2 (ru) * 1995-02-03 2000-10-20 Ле Лабораториз Аетерна Инк. Экстракты хрящей акулы, способ их получения и применения
IT1275905B1 (it) 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
CA2175985A1 (en) * 1995-05-10 1996-11-11 Yoichi Kiyosuke Pharmaceutical composition containing substance inhibiting hsp47 production
DE19627344A1 (de) * 1996-07-01 1998-01-08 Vitasyn Gmbh Entwicklung & Ver Therapeutisch wirksame bzw. gesundheitsfördernde Zubereitung aus definierten Polyphenolverbindungen
JPH10101624A (ja) 1996-10-01 1998-04-21 Juzo Udaka ポリアミンの製造法
JPH10175874A (ja) * 1996-12-19 1998-06-30 Suntory Ltd 抗アレルギー剤
DE19824727A1 (de) * 1998-06-03 1999-12-09 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Catechinen oder einem Gehalt an Extrakt von grünem Tee
WO2000000194A1 (en) * 1998-06-27 2000-01-06 Photogenesis, Inc. Ophthalmic uses of ppargamma agonists and ppargamma antagonists
SE9900473D0 (sv) * 1999-02-12 1999-02-12 Karolinska Innovations Ab Inhibitor of endothelial cell proliferation

Also Published As

Publication number Publication date
JP2003519654A (ja) 2003-06-24
HK1043052A1 (en) 2002-09-06
WO2001051048A1 (en) 2001-07-19
CA2366621A1 (en) 2001-07-19
HK1043052B (en) 2009-12-24
US6248341B1 (en) 2001-06-19
AU781949B2 (en) 2005-06-23
DE60140234D1 (de) 2009-12-03
AU2639201A (en) 2001-07-24
EP1162968B1 (de) 2009-10-21
EP1162968A1 (de) 2001-12-19
ES2332704T3 (es) 2010-02-11

Similar Documents

Publication Publication Date Title
ATE446088T1 (de) Epigallocatechin-gallate zur hemmung von angiogenese
EP1446115A4 (de) Cyanoalkylamino-derivate als protease-hemmer
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
NO20033950D0 (no) N¶rende farmasöytisk preparat omfattende polyfenoler og anvendelse i behandling av kreft
ATE371475T1 (de) Methoden zur behandlung der hautpigmentierung
PL363168A1 (pl) Cyklopentanole, kompozycje zawierające takie związki i sposoby leczenia
PT939627E (pt) Pentafluorobenzenossulfonamidas e analogos
PA8521801A1 (es) Derivados de ciclopentil-glutaramida como inhibidores de endopeptidasa neutra
PT1115701E (pt) Ureias de arilsulfonanilida
ATE421877T1 (de) Verwendung von totarol zur behandlung von pruritus
DE60111362D1 (de) Stabilisierte ascorbinsäure-lösungen
ATE311871T1 (de) Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten
ATE309995T1 (de) Substituierte (aminoiminomethyl oder aminomethyl) dihydrobenzofurane und benozopyrane
EA200100141A1 (ru) Терапевтическая композиция на основе изофлавоноидов для применения в лечении опухолей цитотоксическими агентами
ATE402694T1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz
ATE248845T1 (de) Arylsulfonanilid-phosphate
PT1268463E (pt) 4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao
PT1259502E (pt) Analogos biologicamente activos da discodermolida
ATE315387T1 (de) Verwendung von substituierten 6- dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
ATE270895T1 (de) Topische verwendung von ätherischen ölen zur behandlung von wundheilungsstörungen
DE59908268D1 (de) Khellin-zubereitung und deren verwendung zur topischen therapie
DE602004016841D1 (de) Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen
BR0111814A (pt) Composição farmacêutica e produtos que compreende derivados de distamicina acriloìla substituìda, taxanos e/ou antimetabólitos para terapia combinada contra tumores e seu uso
PT1232173E (pt) Derivados do acido fusidico

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties